Safe and pragmatic use of sodium-glucose co-transporter 2 (SGLT 2) inhibitors: medication counseling

by S. Kalra, A. H. Aamir, M. F. Amin, S. Bajaj, U. Bulugahapitiya, A. K. Das, S. Ghosh, S. Gunatilake, S. A. Mahar, N. Qureshi, S. A. Raza, D. Shrestha, N. Somasundaram, M. Sumanatilleke, A. Wijesinghe
Published 2016-08-01

Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement

by Sanjay Kalra, A H Aamir, Abbas Raza, A K Das, A K Azad Khan, Dina Shrestha, Md Faisal Qureshi, Md Fariduddin, Md Faruque Pathan, Fatema Jawad, Jyoti Bhattarai, Nikhil Tandon, Noel Somasundaram, Prasad Katulanda, Rakesh Sahay, Sanjib Dhungel, Sarita Bajaj, Subhankar Chowdhury, Sujoy Ghosh, S V Madhu, Tofail Ahmed, Uditha Bulughapitiya
Published 2015-01-01

Safe and pragmatic use of sodium–glucose co-transporter 2 inhibitors in type 2 diabetes mellitus: South Asian Federation of Endocrine Societies consensus statement

by Sanjay Kalra, Sujoy Ghosh, A H Aamir, Md. Tofail Ahmed, Mohammod Feroz Amin, Sarita Bajaj, Manash P Baruah, Uditha Bulugahapitiya, A K Das, Mimi Giri, Sonali Gunatilake, Saeed A Mahar, Md. Faruque Pathan, Nazmul Kabir Qureshi, S Abbas Raza, Rakesh Sahay, Santosh Shakya, Dina Shreshta, Noel Somasundaram, Manilka Sumanatilleke, A G Unnikrishnan, Achini Madushani Wijesinghe
Published 2017-01-01